Completed PHASE1 INTERVENTIONAL 2-arm NCT01363076

The Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years

A Study of the Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years

Sponsor: Egalet Ltd

Conditions Postoperative Pain

Interventions Ketorolac Tromethamine

Updated 6 times since 2017 Last updated: Feb 7, 2017 Started: Jun 30, 2007 Primary completion: Jan 31, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01363076, this PHASE1 trial focuses on Postoperative Pain and remains completed. Sponsored by Egalet Ltd, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Egalet Ltd

Data source: Egalet Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States